Early research (Phase 1)Ended earlyNCT06336148What this trial is testingA Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Actym Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Ended earlyNCT03066206What this trial is testingPoziotinib in EGFR Exon 20 Mutant Advanced NSCLCWho this might be right forEGFR Exon 20 MutationERBB2 Gene MutationRecurrent Lung Non-Small Cell Carcinoma+1 more M.D. Anderson Cancer Center 93
Early research (Phase 1)Looking for participantsNCT06561685What this trial is testingLY4050784 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forMetastatic Solid TumorAdvanced Solid TumorNon-small Cell Lung Cancer+1 more Eli Lilly and Company 340
Testing effectiveness (Phase 2)Study completedNCT03997968What this trial is testingCYT-0851 in B-Cell Malignancies and Advanced Solid TumorsWho this might be right forMalignancyNon-hodgkin LymphomaMultiple Myeloma+12 more Cyteir Therapeutics, Inc. 169
Testing effectiveness (Phase 2)UnknownNCT05332574What this trial is testingA Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid TumorWho this might be right forNSCLCOther Solid Tumors Genor Biopharma Co., Ltd. 120
Testing effectiveness (Phase 2)Ended earlyNCT04442126What this trial is testingNM21-1480 in Adult Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorNon-small Cell Lung CancerColorectal Cancer+6 more Numab Therapeutics AG 52
Early research (Phase 1)Looking for participantsNCT06307925What this trial is testingA Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor HC Biopharma Inc. 122
Testing effectiveness (Phase 2)Study completedNCT01625234What this trial is testingPhase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung CancerWho this might be right forAdvanced Solid TumorsNon-small Cell Lung Cancer Xcovery Holdings, Inc. 131
Early research (Phase 1)Study completedNCT00045006What this trial is testingSuberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01325558What this trial is testingALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced Malignant NeoplasmMalignant Solid Tumour Altor BioScience 30
Early research (Phase 1)Looking for participantsNCT04389632What this trial is testingSigvotatug Vedotin in Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more Seagen, a wholly owned subsidiary of Pfizer 1,006
Testing effectiveness (Phase 2)Active Not RecruitingNCT05879822What this trial is testingEvaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor NaiveWho this might be right forAdvanced Solid Tumor Incyte Corporation 73
Early research (Phase 1)Looking for participantsNCT07334119What this trial is testingSafety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid TumorsWho this might be right forHER2-Expressing Solid Tumors Myeloid Therapeutics 60
Testing effectiveness (Phase 2)Looking for participantsNCT05272709What this trial is testingTT-702 in Patients With Advanced Solid Tumours.Who this might be right forAdvanced Solid Tumors Cancer Research UK 60
Testing effectiveness (Phase 2)Looking for participantsNCT07189871What this trial is testing177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsWho this might be right forCastration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more Radiopharm Theranostics, Ltd 61
Early research (Phase 1)Active Not RecruitingNCT04007744What this trial is testingSonidegib and Pembrolizumab in Treating Patients With Advanced Solid TumorsWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+19 more Mayo Clinic 36
Early research (Phase 1)Study completedNCT06131398What this trial is testingAMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Amgen 77
Not applicableEnded earlyNCT05891197What this trial is testingA Biomarker Screening Protocol for Participants With Solid TumorsWho this might be right forTriple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more Lyell Immunopharma, Inc. 10
Early research (Phase 1)Looking for participantsNCT07085091What this trial is testingA First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid TumorsWho this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)HNSCCCRC (Colorectal Cancer)+4 more ALX Oncology Inc. 170
Early research (Phase 1)Study completedNCT03595059What this trial is testingA Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 168